Mouw Named Medical Director of UMC Cancer Center
Tyler J. Mouw, M.D., has been appointed medical director of the UMC TLC² Foundation Cancer Center in Lubbock, Texas.
Updated on Nov. 10, 2026 in People
Live Poll
Do you trust local hospitals to provide advanced cancer care close to home?
TTUHSC and UMC Health System have appointed Tyler J. Mouw, M.D., as medical director of the UMC TLC² Foundation Cancer Center. Mouw previously served as interim medical director of the cancer center.
Why it matters
The appointment places a surgical oncologist with a formal leadership role over the cancer center's services in Lubbock. It reflects the continued integration of Texas Tech physicians and UMC Health System oncology care.
The announcement contains no quantitative business metrics; the appointment is a single leadership change from interim to medical director. The source does not disclose compensation, staffing levels or patient volume figures for the cancer center.
The players
Tyler J. Mouw, M.D.
Mouw is a surgeon who completed training in complex general surgical oncology and hepatobiliary surgery at the University of Louisville.
UMC Health System
UMC Health System is a Lubbock-based hospital system that operates the UMC TLC² Foundation Cancer Center.
Texas Tech University Health Sciences Center
The Texas Tech University Health Sciences Center, known as TTUHSC, operates the School of Medicine where Mouw leads surgical oncology.
The details
Mouw serves as division chief of surgical oncology and hepatobiliary surgery at the TTUHSC School of Medicine, chief of surgical oncology at Texas Tech Physicians, and medical director of oncologic surgery at UMC. The cancer center offers HIPEC for abdominal cancer and Histotripsy, a non-invasive procedure that uses focused sound waves to destroy and liquefy liver tumors.
Timeline
Tuesday: press release announcing Mouw's appointment was obtained
This year: Histotripsy procedure introduced at the cancer center
Market Landscape
The appointment ties an academic surgical oncology division to a community hospital cancer center, a pattern of academic-community partnership in Lubbock's regional oncology market. It positions the cancer center to compete for complex hepatobiliary and abdominal cancer surgery referrals.
Patients seeking cancer surgery in Lubbock may find the cancer center's leadership now led by a permanent medical director with advanced surgical oncology training. The center's offerings include HIPEC and Histotripsy for liver tumors, which may be relevant to patients evaluating treatment options.
The takeaway
Patients considering abdominal or liver cancer treatment in Lubbock can ask their care team whether HIPEC or Histotripsy is an option for their case.
Further reading
Explore more People coverage tied to Lubbock's healthcare leadership moves.
Source note: This article includes information reported by Home Page.
Live Poll
Do you trust local hospitals to provide advanced cancer care close to home?
